A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Type I Collagen Treatment in Patients With Diffuse Cutaneous Systemic Sclerosis: I. Oral Type I Collagen Does Not Improve Skin in All Patients, but May Improve Skin in Late-Phase Disease

OBJECTIVE: To investigate the safety and efficacy of oral bovine type I collagen (CI) treatment in patients who have had diffuse cutaneous systemic sclerosis (dc-SSc; scleroderma) for ≤10 years. METHODS: One hundred sixty-eight patients with dcSSc were enrolled in a double-blind, placebo-controlled...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Arthritis Rheum
Κύριοι συγγραφείς: Postlethwaite, Arnold E., Wong, Weng Kee, Clements, Philip, Chatterjee, Soumya, Fessler, Barri J., Kang, Andrew H., Korn, Joseph, Mayes, Maureen, Merkel, Peter A., Molitor, Jerry A., Moreland, Larry, Rothfield, Naomi, Simms, Robert W., Smith, Edwin A., Spiera, Robert, Steen, Virginia, Warrington, Kenneth, White, Barbara, Wigley, Frederick, Furst, Daniel E.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2008
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4511098/
https://ncbi.nlm.nih.gov/pubmed/18512816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.23501
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια